CEFDINIR
- Product NDC
- 61919-840
- 11-digit product format
- 619190840
- Labeler code
- 61919
- Product ID
- 61919-840_f215bd63-3820-508b-e053-2a95a90aaa48
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CEFDINIR
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- DirectRX
- Application
- ANDA065434
- Marketing category
- ANDA
- Marketing start
- 2019-04-29
- Marketing end
- 0000-00-00
- Substance
- CEFDINIR
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-840-14 | CEFDINIR | 14 in 1 BOTTLE | CAPSULE | 14 | | 3 |
| 61919-840-20 | CEFDINIR | 20 in 1 BOTTLE | CAPSULE | 20 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-840 | CEFDINIR CAPSULE [DIRECTRX] | 3 | Legacy NDC, 2 package rows | 20230113_87af716a-6564-ceee-e053-2a95a90a6679.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-840-14 | 61919084014 | 14 CAPSULE in 1 BOTTLE (61919-840-14) | 14 capsule | 2019-04-29 | 0000-00-00 | No | No | Current |
| 61919-840-20 | 61919084020 | 20 CAPSULE in 1 BOTTLE (61919-840-20) | 20 capsule | 2019-04-29 | 0000-00-00 | No | No | Current |